Bopitiya Ranmali
Known title: EVP & Chief Legal OfficerCIK: 0001908069
Associated companies
Transaction History
| OSCR | ▼ Sell | Open Market | 18,812 | $340K | 12/2/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 345 | $6K | 12/2/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,447 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,424 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 4,867 | — | 12/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 14,820 | $265K | 9/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 18,158 | $317K | 9/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 36,175 | $651K | 9/3/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,448 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 4,867 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 108,932 | — | 9/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 447 | $9K | 6/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 17,168 | $334K | 6/3/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,447 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 4,867 | — | 6/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 11,426 | $181K | 3/4/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 3/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,447 | — | 3/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 42,865 | $773K | 2/16/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 12,625 | $105K | 12/4/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 12/1/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,448 | — | 12/1/2023 | View on chart |
| OSCR | ▼ Sell | Open Market | 11,749 | $73K | 9/5/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,424 | — | 9/1/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,447 | — | 9/1/2023 | View on chart |
| OSCR | ▼ Sell | Open Market | 11,597 | $83K | 6/2/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 16,447 | — | 6/1/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 6/1/2023 | View on chart |
| OSCR | ▼ Sell | Open Market | 7,252 | $34K | 3/2/2023 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 3/1/2023 | View on chart |
| OSCR | ▼ Sell | Open Market | 6,281 | $18K | 12/2/2022 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 12/1/2022 | View on chart |
| OSCR | ▼ Sell | Open Market | 6,167 | $36K | 9/2/2022 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,425 | — | 9/1/2022 | View on chart |
| OSCR | ▼ Sell | Open Market | 5,961 | $28K | 6/2/2022 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 20,424 | — | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.